MarketInOut Stock Screener Log In | Sign Up
 

Oruka Therapeutics Inc

NASDAQ • Healthcare • Biotechnology • Quote as of 05/13/2026 16:00
Oruka Therapeutics Inc stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization3,952.35 mln
Float41.84 mln
Earnings Date05/20/2026

1-Year Forecast

142
Transformational upside

Relative Strength

14 / 100
Significantly lagging

Debt / Equity

0.00
Debt-free

ROE

-25.80
Deeply negative

Dividend Yield

0.00%
No dividend

DPS

0.00
No dividend

Business Description

Oruka Therapeutics is a clinical-stage medicine company based in Menlo Park, California, working to develop new antibody-based treatments for psoriasis and related inflammatory conditions. Its two lead treatments, ORKA-001 and ORKA-002, are currently in mid-stage clinical trials targeting different proteins involved in driving inflammation. The company is also exploring additional treatment approaches, including a combined therapy that uses both lead drugs in sequence.

Key Fundamentals

EPS-1.85
ROE-25.80
ROIC-154
ROA-24.77
EBITDA, mln-105
EV / EBITDA-35.03
EV / EBIT-35.00

Financial Strength

1-Year Target Price142
Short Ratio4.89
Short % of Float18.79

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -9.47% 12 / 100   
1 Month -5.79% 20 / 100   
2 Months 91.45% 97 / 100   
6 Months 126% 97 / 100   
1 Year 548% 99 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Contact Us